{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-008843","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.074125+00:00","generated_at":"2026-05-16T14:06:10.969133+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Paul Mann to resume CEO role at ASP Isotopes on Jan 19, 2026; Ainscow returns to COO","bullets":["Founder/Exec Chairman Paul Mann reassumes CEO role effective Jan 19, 2026, after medical leave.","Interim CEO Robert Ainscow will continue as COO; no new compensatory arrangements disclosed.","The transition is a planned succession; no agreement with any other person for Mann's appointment.","Mann's biographical info is incorporated from the Nov 25, 2025 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-008843","json":"https://secwatch.observer/filing/0001477932-25-008843.json","markdown":"https://secwatch.observer/filing/0001477932-25-008843.md","text":"https://secwatch.observer/filing/0001477932-25-008843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000147793225008843/0001477932-25-008843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000147793225008843/aspi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:06:10.969133+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}